1 in 5 Alzheimer's patients misdiagnosed?; Smartphone app improves colonoscopy prep;

News From Around the Web

> Nearly one out of five patients diagnosed with Alzheimer's disease are misdiagnosed, according to a study sponsored by pharmaceutical company Eli Lilly. The study is part of the company's campaign to get Medicare to cover the use of the imaging agent Amyvid, which is used in PET imaging to evaluate Alzheimer's. Article

> A smartphone application called the "Arizona Digestive Health" app helps improve colonoscopy preparation, according to research presented at Digestive Disease Week 2013 in Orlando earlier this month. With the application patients enter the date and time of the procedure and the bowel preparation medication chosen by their physician. Timed alerts then appear on the phone to remind the individual of the next step in bowel preparation. In addition to the alerts, the app offers information explaining the procedure, tips and pictures of preparation quality. Announcement

> A new imaging technique that combines electroencephalogram (EEG) with functional magnetic resonance imaging (fMRI) technology can help improve the treatment of patients with epilepsy, iTechPost reports. The new technique gives doctors more precise readings of the origin of epileptic seizures in patients' brains. Article

Health IT News

> A new report from the Institute of Health Technology Transformation (iHT2) resonates a familiar theme: Analytics are the key to population health management and accountable care organizations. Article

Health Finance News

> Hospitals are raising objections to a proposed rule that would allow them to rebill the Medicare program for Part B claims that had been denied by auditors based on the setting where the care was rendered. Article

And Finally… The ghost and the Japanese prime minister. Article